Consolidated Planning Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
646
-8
-1% -$2.85K 0.04% 136
2025
Q4
$214K Buy
+654
New +$207K 0.02% 195
2025
Q3
Sell
-4,380
Closed -$1.22M 195
2025
Q2
$1.22M Sell
4,380
-997
-19% -$282K 0.15% 110
2025
Q1
$1.68M Buy
5,377
+3,628
+207% +$1.07M 0.23% 87
2024
Q4
$456K Sell
1,749
-766
-30% -$227K 0.06% 134
2024
Q3
$811K Buy
2,515
+1,842
+274% +$603K 0.12% 101
2024
Q2
$210K Buy
+673
New +$198K 0.03% 180
2024
Q1
Sell
-728
Closed -$210K 185
2023
Q4
$210K Buy
+728
New +$198K 0.04% 162
2021
Q4
Sell
-483
Closed -$103K 84
2021
Q3
$103K Buy
+483
New +$111K 0.07% 99

Other funds holding AMGN

Consolidated Planning Corp's AMGN Position: Q1 2026 in Review

Consolidated Planning Corp reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $2.85K and leaving 646 shares worth $227K. The position accounts for 0.04% of the portfolio, ranked #136.

Consolidated Planning Corp first reported a position in AMGN in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.68M in Q1 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Consolidated Planning Corp held 646 shares of Amgen worth $227K as of Q1 2026.
  • Consolidated Planning Corp sold 8 Amgen shares in Q1 2026, an estimated $2.85K.
  • Amgen made up 0.04% of Consolidated Planning Corp's portfolio in Q1 2026, its #136 holding.
  • Consolidated Planning Corp first reported a position in Amgen in Q3 2021 and has held it in 9 quarters since.
  • Consolidated Planning Corp's Amgen position peaked at $1.68M in Q1 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Consolidated Planning Corp's 13F filing for Q1 2026, filed 16 Apr 2026.